Add time:07/28/2019         Source:sciencedirect.com

In search of antiinflammatory drugs with a new mechanism of action, U0126 was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with an IC50 of 0.07 μM for MEK 1 and 0.06 μM for MEK 2. U0126 can undergo isomerization and cyclization reactions to form a variety of products, both chemically and in vivo, all of which exhibit less affinity for MEK and lower inhibition of AP-1 activity than parent, U0126.

We also recommend Trading Suppliers and Manufacturers of U0126 (cas 109511-58-2). Pls Click Website Link as below: cas 109511-58-2 suppliers